FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing AuthorizationMay 23, 2024 First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients Tel Aviv, Israel,…
Innoveren Scientific’s (OTCMKTS: IVRN) 510(k) Submission Sparks A New Hope For Patients Living With Chronic Non-Healing WoundsMarch 8, 2024 IVRN has completed a 510(k) submission for its SkinDiscTM Lite and SkinDiscTM regenerative medicine technology. The company says that what differentiates this technology…
